Ferguson P R
Department of Law, University of Dundee, Dundee, UK.
J Med Ethics. 2002 Feb;28(1):45-8. doi: 10.1136/jme.28.1.45.
According to the Declaration of Helsinki, patients who take part in a clinical trial must be adequately informed about the trial's aims, methods, expected benefits, and potential risks. The declaration does not, however, elaborate on what "adequately informed" might amount to, in practice. Medical researchers and Local Research Ethics Committees attempt to ensure that the information which potential participants are given is pitched at an appropriate level, but few studies have considered whether the patients who take part in such trials feel they have been given adequate information, or whether they feel able to understand that information.
To explore trial participants' views (i) on the amount of information provided, and (ii) of their own understanding of that information.
Structured interviews of patients participating in clinical trials for the treatment of chronic medical condition.
Patients generally felt they were given an appropriate amount of information, and that they were able to understand all or most of it. They felt they were given adequate time to ask questions before agreeing to take part. In comparison with treatment given out with the research setting, patients generally felt they received more information when participating in a clinical trial.
Researchers sometimes complain that patients are given too much information during clinical trials, and have limited understanding of that information. The present study shows that this perception is not necessarily shared by patients. More research is needed in this area, particularly to gauge whether patient understanding is indeed accurate.
根据《赫尔辛基宣言》,参与临床试验的患者必须充分了解试验的目的、方法、预期益处和潜在风险。然而,该宣言并未详细说明在实际操作中“充分了解”具体意味着什么。医学研究人员和地方研究伦理委员会试图确保向潜在参与者提供的信息水平适当,但很少有研究考虑参与此类试验的患者是否觉得自己得到了充分的信息,或者他们是否觉得自己能够理解这些信息。
探讨试验参与者对(i)所提供信息的数量,以及(ii)他们对这些信息的自身理解的看法。
对参与慢性疾病治疗临床试验的患者进行结构化访谈。
患者普遍认为他们得到了适量的信息,并且能够理解全部或大部分信息。他们觉得在同意参与之前有足够的时间提问。与在研究环境之外接受的治疗相比,患者普遍觉得参与临床试验时获得了更多信息。
研究人员有时抱怨在临床试验期间给患者提供了过多信息,且患者对这些信息的理解有限。本研究表明,患者不一定有同样的看法。该领域需要更多研究,特别是要评估患者的理解是否确实准确。